Infusion Options RITUXIMAB 575 MG / 250 ml 0.9% NACL IVPB recall — FDA D-1810-2019
Lack of Assurance of Sterility
Browse U.S. drug recall enforcement reports from the FDA in a structured, searchable format. Review the recalled product, reason, firm, status, dates, distribution information and FDA classification when available.
10,690 detailed records are currently available in this category.
Lack of Assurance of Sterility
Failed Impurities/Degradation Specifications; out of specification result for an unknown impurity in stability samples.
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Lack of Assurance of Sterility
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Lack of Assurance of Sterility
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.
Labeling; Incorrect or Missing Lot Number and/or Exp Date; Product has an incorrect expiration date of 9/2022 applied to the labeling, where the actual expiration date is 10/2021.
CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.
CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.
CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.
CGMP Deviations: Finished product made with lovastatin drug substance that was out of specification for individual impurity results.
CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.
CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.
Lack of Assurance of Sterility
GMP Deviations: Glenmark received complaints stating that mometasone fuorate cream was gritty.
CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.
CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.
CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.
A drug recall record can include the reason for recall, firm, status, distribution pattern, quantity and FDA classification. This site does not provide medical advice; it organizes public recall information and links users back to official sources.
Recall Lookup USA keeps the last complete source record available when an official data service is temporarily unavailable. When a source provides only a few fields, we show only those known facts rather than padding the page with generic text.
This database is designed for discovery and reference. It can help you locate a relevant recall record, identify the recalling firm or NHTSA campaign, compare dates and classifications, and follow the official source. It is not a substitute for a VIN-specific NHTSA check, a manufacturer notice, medical advice or instructions issued by the recalling company.